Avadel Pharmaceutica
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
March 02, 2017 07:30 ET | Avadel Pharmaceuticals plc
DUBLIN, Ireland, March 02, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced that management will present at two upcoming investor conferences: The 29th Annual ROTH...
Avadel Pharmaceutica
Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2016 Results
February 14, 2017 07:30 ET | Avadel Pharmaceuticals plc
DUBLIN, Ireland, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced it will report its fourth quarter and full year 2016 financial results on Tuesday, March...
Avadel Pharmaceutica
Avadel Pharmaceuticals to Present at Two Upcoming Investor Conferences
February 06, 2017 07:30 ET | Avadel Pharmaceuticals plc
DUBLIN, Ireland, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced that management will present at two upcoming investor conferences: LEERINK Partners 6th...
CORRECTING and REPLA
CORRECTING and REPLACING – Avadel Pharmaceuticals Provides 2017 Guidance and Business Update
January 05, 2017 08:17 ET | Avadel Pharmaceuticals plc
In a release issued under the same headline earlier today by Avadel Pharmaceuticals plc (NASDAQ:AVDL) please note that in the second subhead of the release, the Adjusted Diluted EPS...
Avadel Pharmaceutica
Avadel Pharmaceuticals Provides 2017 Guidance and Business Update
January 05, 2017 07:30 ET | Avadel Pharmaceuticals plc
Full Year 2017 Revenue Guidance of $170 - $200 million Adjusted Diluted EPS of $0.20 - $0.30 DUBLIN, Ireland, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), today...
Avadel Pharmaceutica
Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer
January 03, 2017 16:03 ET | Avadel Pharmaceuticals plc
DUBLIN, Ireland, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL) today announced the addition of Gregory J. Divis as Executive Vice President and Chief Commercial Officer,...
Flamel Technologies
Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc
January 03, 2017 07:30 ET | Avadel Pharmaceuticals plc
DUBLIN, Ireland, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Flamel Technologies SA, completed its previously announced cross-border merger with and into its wholly-owned Irish subsidiary, Avadel...